Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis

References

• Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999;281:1628–31.
   PubMed Web of Science ®Google Scholar
• Morita R, Ishikawa J, Tsutsumi M, Hikiji K, Tsukada Y, Kamidono S, Allelotype of renal cell carcinoma. Cancer Res 1991;51:820–3.
   PubMed Web of Science ®Google Scholar
• Béroud C, Joly D, Gallou C, Staroz F, Orfanelli MT, Junien C. Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 1998;26:256–8.
   PubMed Web of Science ®Google Scholar
• Giménez Bachs JM, Salinas Sánchez AS, Sánchez Sánchez F, Lorenzo Romero JG, Donate Moreno MJ, Pastor Navarro H, Determination of vhl gene mutations in sporadic renal cell carcinoma. Eur Urol 2006;49:1051–7.
   PubMed Web of Science ®Google Scholar
• Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994;91:9700–4.
   PubMed Web of Science ®Google Scholar
• Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009;373:1119–32.
   PubMed Web of Science ®Google Scholar
• Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000;60:7075–83.
   PubMed Web of Science ®Google Scholar
• Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE, Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel–Lindau transgenes. Proc Natl Acad Sci USA 1998;95:12596–601.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Kanda K, Tsuji M, Kanayama H, Kagawa H. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma. BJU Int 1999;83:743–7.
   PubMed Web of Science ®Google Scholar
• Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 1997;57:2827–31.
   PubMed Web of Science ®Google Scholar
• Ljungberg B. Prognostic markers in renal cell carcinoma. Curr Opin Urol 2007;17:303–8.
   PubMed Web of Science ®Google Scholar
• Kim HL, Seligson D, Liu X, Janzen N, Bui M, Yu H, Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res 2004;10:5464–71.
   PubMed Web of Science ®Google Scholar
• Panelli MC, Wang E, Marincola FM. The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness. Clin Cancer Res 2005;11:3601–3.
   PubMed Web of Science ®Google Scholar
• Nese N, Paner GP, Mallin K, Ritchey J, Stewart A, Amin MB. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base. Ann Diagn Pathol 2009;13:1–8.
   PubMed Web of Science ®Google Scholar
• Young AN, Master VA, Paner GP, Wang MD, Amin MB. Renal epithelial neoplasms: diagnostic applications of gene expression profiling. Adv Anat Pathol 2008;15:28–38.
   PubMed Web of Science ®Google Scholar
• Barocas DA, Rohan SM, Kao J, Guverich RD, Del Pizzo JJ, Vaughan ED, Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. J Urol 2006;176:1957–62.
   PubMed Web of Science ®Google Scholar
• Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004.
   Google Scholar
• Kaluz S, Kaluzová M, Stanbridge EJ. The role of extracellular signal-regulated protein kinase in transcriptional regulation of the hypoxia marker carbonic anhydrase IX. J Cell Biochem 2006;97:207–16.
   PubMed Web of Science ®Google Scholar
• Opavsky R, Pastorekova S, Zelnik V, Gibadulinova A, Stanbridge EJ, Zavada J, Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 1996;33:480–7.
   PubMed Web of Science ®Google Scholar
• Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 2001;158:905–19.
   PubMed Web of Science ®Google Scholar
• Gilbert SM, Whitson JM, Mansukhani M, Buttyan R, Benson MC, Olsson CA, Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors. Urology 2006;67:942–5.
   PubMed Web of Science ®Google Scholar
• Young AN, Dale J, Yin-Goen Q, Harris WB, Petros JA, Datta MW, Current trends in molecular classification of adult renal tumors. Urology 2006;67:873–80.
   PubMed Web of Science ®Google Scholar
• Leppert JT, Lam JS, Pantuck AJ, Figlin RA, Belldegrun AS. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma. BJU Int 2005;96:281–5.
   PubMed Web of Science ®Google Scholar
• Said J. Biomarker discovery in urogenital cancer. Biomarkers 2005;10(Suppl 1):S83–6.
   PubMedGoogle Scholar
• Ficarra V, Galfano A, Novara G, Iafrate M, Brunelli M, Secco S, Risk stratification and prognostication of renal cell carcinoma. World J Urol 2008;26:115–25.
   PubMed Web of Science ®Google Scholar
• Salama ME, Worsham MJ, DePeralta-Venturina M. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization. Arch Pathol Lab Med 2003;127:1176–81.
   PubMed Web of Science ®Google Scholar
• Rubio Briones J, Algaba Arrea F, Almenar S, Solsona Narbon E. Inmunohistoquímica aplicada en Urología. Actas Urol Esp 1999;23:819–34.
   PubMedGoogle Scholar
• Sandlund J, Oosterwijk E, Grankvist K, Oosterwijk-Wakka J, Ljundberg B, Rasmuson T. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma. BJU Int 2007;100:556–60.
   PubMed Web of Science ®Google Scholar
• Atkins M, Regan M, McDermott D, Mier J, Stanbridge E, Youmans A, Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 2005;11:3714–21.
   PubMed Web of Science ®Google Scholar
• Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 2003;9:802–11.
   PubMed Web of Science ®Google Scholar
• Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Chevide JC, Zavada J, Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol 2007;25:4757–64.
   PubMed Web of Science ®Google Scholar